IBMSol
Latest round
- Seed
Last raised
- Sep 2021
Total raised
- Undisclosed
Investors
- 2
About IBMSol
IBMSol, founded in 2020 and headquartered in Seoul, South Korea, specializes in bio-medical innovations. The company's inception marked its commitment to developing sophisticated medical technologies.IBMSol specializes in innovative bio-medical solutions, focusing on the development and commercialization of advanced medical devices and therapies. Their core product offerings include a non-invasive cancer treatment technology based on bio-plasma, ultrasonic probe sterilizers, and infection management systems, along with targeted drug development for rare diseases. These products are designed to improve patient outcomes by providing effective treatment options while minimizing complications associated with traditional methods. The company's technology aims to address critical healthcare challenges, particularly in oncology and infectious disease management.IBMSol operates with a revenue model that encompasses B2B transactions, primarily through direct sales to healthcare institutions and partnerships with medical distributors. The company generates income through the sale of its flagship products, including the bio-plasma based cancer treatment system and sterilizers, which are essential tools for modern medical facilities. Revenue streams are structured around one-time purchases, with potential for recurring sales as healthcare providers replenish inventory of consumable supplies or upgrade systems. This transactional framework supports a robust relationship with clients who benefit from the advanced technologies that enhance their medical offerings.IBMSol plans to launch several new products designed to advance its medical technology offerings within the next year. The company is also targeting expansion into Southeast Asian markets by 2023, focusing on regions that demonstrate a growing demand for modern healthcare solutions.
Who invested in IBMSol
2 investors across 1 round
See all investors in IBMSol
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 30, 2021
Amount
Undisclosed
Investors
Questions about IBMSol
Who invested in IBMSol?
IBMSol has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IBMSol raised?
IBMSol has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did IBMSol last raise money?
IBMSol's most recent round on record is a Seed, in Sep 2021.
What does IBMSol do?
IBMSol, founded in 2020 and headquartered in Seoul, South Korea, specializes in bio-medical innovations.
Where is IBMSol headquartered?
IBMSol is headquartered in Seoul, South Korea.
Which VCs invest in companies like IBMSol?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at IBMSol's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like IBMSol? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.